CTLA4 and myeloid sarcoma: Overall, this study highlighted that the CTLA-4 gene could be involved in the genetic susceptibility to MS and suggested that a dysregulation of the CTLA-4-driven downregulation of T-cell activation might be implicated in the pathogenesis of MS [117].